The 0.8-kilobase segment of the mouse 202 gene functions as an interferon-activatable enhancer capable of activating heterologous promoters in an orientation- and position-independent manner.
No takes yet. Share an insight, caveat, or question.
Does not alter cardiovascular practice; leaves open translational relevance of interferon enhancers in human disease models.
Gribaudo et al. (1987) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: